Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 21, 2019
Marken has announced that its nursing services for home-based clinical trials are now operational in most key markets around the world, which can be integrated into its already well-established logistics network. The home healthcare offering extends ...
read more
Marken announced today that it has been granted approval for a customs-bonded warehouse within the Marken depot in Frankfurt, Germany. This will allow Marken to store pharmaceuticals with an origin outside the European Union (EU) and distribute them ...
read more
Marken announced today that it has opened its first office in South Korea. The office will manage customer service operations and offer local service to its customers who currently operate in the South Korea. Marken currently operates in the ...
read more
Wednesday, December 11, 2013
Marken announced today that their Singapore biological kit-building facility has now been certified to International Standards Organization (ISO) 13485 standards for the storage and distribution of medical devices.
read more
Marken announced today that they will host an industry workshop to discuss the emerging direct to patient clinical trial market, and that they have forged a global co-marketing relationship with GlobalCare Clinical Trials, Ltd, the leading global ...
read more
Marker Therapeutics has announced the appointment of Nadia Agopyan, Ph.D., RAC as Vice President of Regulatory Affairs, effective August 15.
"We are pleased to welcome a professional of Nadia's caliber and senior leadership experience to Marker," ...
read more
Wednesday, October 07, 2020
MCRA has announced its role in the successful management and execution of Simplify Medical's clinical study and approval by the FDA of their PMA for the Simplify Disc.
read more
Monday, February 14, 2022
mdgroup, a leading global medtech and patient health services company pioneering a patient-first approach to clinical research, has been named as one of the UK's fastest-scaling businesses in 2021's Organic Growth 25 (OG25) index in recognition of ...
read more
As the pharmaceutical industry embraces increased transparency, medical publications teams require the resources to support a growing demand for abstracts and manuscripts. According to a recent study by life sciences intelligence firm Cutting Edge ...
read more
Thursday, January 27, 2022
Medidata, a Dassault Systèmes company, announced a partnership with Circuit Clinical, an Integrated Research Organization (IRO). Circuit Clinical has created a network representing over 90 doctors, across 30+ site locations, and a nationally ...
read more
Mednet, a healthcare technology company, announced its latest software release featuring expanded trial supply management capabilities. The new Trial Supply Manager, a component of Mednet's Randomization and Trial Supply Management (RTSM) module, ...
read more
Friday, December 21, 2012
Merck, known as MSD outside the United States and Canada, and GE Healthcare today announced a clinical study collaboration, license and supply agreement for use of [18F]Flutemetamol, an investigational positron emission tomography (PET) imaging agent...
read more
Wednesday, March 13, 2013
Merck, known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's ...
read more
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per ...
read more
Friday, February 15, 2013
Metrics Inc. has added a new formulation scientist to its growing staff of pharmaceutical chemists.
read more